Electrochemical Assessment of CYP3A4 Catalytic Activity in Bactosomes

被引:0
|
作者
Koroleva, Polina I. [1 ,2 ]
Kuzikov, Alexey V. [1 ,2 ]
Gilep, Andrei A. [1 ]
Bulko, Tatiana V. [1 ]
Shumyantseva, Victoria V. [1 ,2 ]
机构
[1] Inst Biomed Chem, Pogodinskaya St 10, Moscow 119121, Russia
[2] Pirogov Russian Natl Res Med Univ, Moscow, Russia
基金
俄罗斯科学基金会;
关键词
Electrochemical analysis; Screen-printed electrodes; Voltammetry; Bioreactor; Electron transfer; Enzymatic assay; LIVER MICROSOMAL BIOREACTOR; DRIVEN DRUG-METABOLISM; CYTOCHROME-P450; 3A4; DICLOFENAC; FILM; BIOCATALYSIS; ACTIVATION; EFFICIENCY; REDUCTASE; KINETICS;
D O I
10.1007/s12668-024-01539-1
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
In this work, we present investigation on the behavior of bactosomes containing human cytochrome CYP3A4 in comparison with recombinant enzyme. The bactosomes were adsorbed on the surface of screen-printed electrodes modified with didodecyldimethylammonium bromide. We have shown that bactosomes are effective bioreactors in the case of drug metabolic electroenzymatic reactions. The electrocatalytic reaction was conducted at a working potential of - 0.50 divided by - 0.55 V. Drug conversion was registered by means of measuring of formaldehyde as product of N-demethylation reaction of erythromycin and time-dependent electrochemical oxidation of diclofenac during electrolysis at controlled working potential. The efficiencies of electrocatalysis of erythromycin N-demethylation as well-known cytochrome P450 3A4 substrate in the case of bactosomes containing human cytochrome P450 3A4 was 3.5 +/- 0.4 times higher in comparison with highly purified cytochrome P450 3A4-electrode as catalyst. The efficiencies of electrocatalysis of diclofenac 5-hydroxylation in the case of bactosomes were 3.1 +/- 0.3 times higher than for purified enzyme. Bactosomes are effective electrochemical enzymatic nanobioreactors with a high electroenzymatic efficiency for metabolite production.
引用
收藏
页码:2930 / 2939
页数:10
相关论文
共 50 条
  • [21] Stability of CYP3A4 activity in cryopreserved human hepatocytes
    Griffin, Michael
    Somers, Graham I.
    Houston, J. Brian
    DRUG METABOLISM REVIEWS, 2006, 38 : 106 - 106
  • [22] Effect of influenza immunization on CYP3A4 activity in vivo
    Hayney, MS
    Muller, D
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (12): : 1377 - 1381
  • [23] Bufalin inhibits CYP3A4 activity in vitro and in vivo
    Hai-yun Li
    Wen Xu
    Xi Zhang
    Wei-dong Zhang
    Li-wei Hu
    Acta Pharmacologica Sinica, 2009, 30 : 646 - 652
  • [24] Lacosamide Has No Effect on the Enzymatic Activity of CYP3A4
    Cawello, Willi
    Surmann, Erwin
    Waitzinger, Josef
    NEUROLOGY, 2012, 78
  • [25] Bufalin inhibits CYP3A4 activity in vitro and in vivo
    Li, Hai-yun
    Xu, Wen
    Zhang, Xi
    Zhang, Wei-dong
    Hu, Li-wei
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (05) : 646 - 652
  • [26] CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin
    Elens, Laure
    Nieuweboer, Annemieke
    Clarke, Stephen J.
    Charles, Kellie A.
    de Graan, Anne-Joy
    Haufroid, Vincent
    Mathijssen, Ron H. J.
    van Schaik, Ron H. N.
    PHARMACOGENOMICS, 2013, 14 (02) : 137 - 149
  • [27] Effect of hemodialysis on hepatic CYP3A4 activity.
    Nolin, TD
    Appiah, K
    Kendrick, SA
    Le, P
    McMonagle, E
    Himmelfarb, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P23 - P23
  • [28] Role of CYP3A4 in human hepatic diltiazem N-demethylation: Inhibition of CYP3A4 activity by oxidized diltiazem metabolites
    Sutton, D
    Butler, AM
    Nadin, L
    Murray, M
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (01): : 294 - 300
  • [29] Effect of Itraconazole, a CYP3A4 Inhibitor, and Rifampin, a CYP3A4 Inducer, on the Pharmacokinetics of Vatiquinone
    Lee, Lucy
    Thoolen, Martin
    Ma, Jiyuan
    Kaushik, Diksha
    Golden, Lee
    Kong, Ronald
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (12): : 1283 - 1290
  • [30] Amino acid 305 determines catalytic center accessibility in CYP3A4
    Fowler, SM
    Riley, RJ
    Pritchard, MP
    Sutcliffe, MJ
    Friedberg, T
    Wolf, CR
    BIOCHEMISTRY, 2000, 39 (15) : 4406 - 4414